Table: Torii Pharmaceutical -9-MTH parent results
Oct 28 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2016 Sep 30, 2015 Dec 31, 2016
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 43.77 44.84 60.50
(-2.4 pct) (-3.0 pct)
Operating 2.57 3.49 3.00
(-26.3 pct) (-39.0 pct)
Recurring 2.71 3.67 3.10
(-26.0 pct) (-39.6 pct)
Net 1.76 2.33 2.10
(-24.7 pct) (-40.5 pct)
EPS 62.04 yen 82.37 yen 74.21 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)